Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex

0.0521
+0.0000
Volume:- -
Turnover:- -
Market Cap:4.87M
PE:-0.04
High:0.0521
Open:0.0521
Low:0.0521
Close:0.0521
Loading ...

Vertex Minerals Starts Trading on US OTCQB Market; Shares Fall 4%

MT Newswires Live
·
31 Mar

IHI to Sell Construction Materials Business to Vertex to Focus on Growth Areas

MT Newswires Live
·
28 Mar

Vertex, Inc. (NASDAQ:VERX) Has Found A Path To Profitability

Simply Wall St.
·
28 Mar

IHI Corporation Transfers Shares of Construction Subsidiary to Vertex

TIPRANKS
·
27 Mar

Vertex Commerce Study: Returnuary’s Growing Complexity Forces Retailers to Keep Pace

GlobeNewswire
·
26 Mar

Explorers Podcast: Vertex ready to claim its gold Reward

Stockheads
·
26 Mar

Press Release: Vertex Resource Group Ltd. Reports Fourth Quarter and Year End 2024 Results

Dow Jones
·
24 Mar

Vertex Price Target Maintained With a $61.00/Share by Citizens Capital Markets

Dow Jones
·
20 Mar

Vertex Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
20 Mar

Vertex’s Ambitious Growth Targets and Uncertain Near-Term Prospects: A Hold Rating Analysis

TIPRANKS
·
20 Mar

Vertex Price Target Maintained With a $60.00/Share by Needham

Dow Jones
·
20 Mar

Vertex’s Strategic Positioning and Growth Potential: A Buy Recommendation by Chris Quintero

TIPRANKS
·
20 Mar

Vertex Highlights Growth Strategies at Investor Day

TIPRANKS
·
20 Mar

Vertex Minerals Adds Remote-Capable Loader to Underground Fleet at New South Wales Gold Mine

MT Newswires Live
·
19 Mar

Vertex Minerals Enhances Reward Gold Mine Operations with New Loader Acquisition

TIPRANKS
·
19 Mar

Goldman Sachs Analyst Anticipates Clarity On Vertex's Investment Roadmap And Product Monetization At Investor Day

Benzinga
·
18 Mar

Vertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?

Zacks
·
17 Mar

Cryptocurrency Payment Platform RedotPay Completes $40 Million Series A Funding Round, Led by Lightspeed

Blockbeats
·
14 Mar

Vertex, Inc. to Host 2025 Investor Day

GlobeNewswire
·
12 Mar

Vertex Announces UK MHRA Approval of ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

Business Wire
·
07 Mar